A NEW CLASS OF THE ANTI-ISCHEMIC MEDICAMENTS - METABOLIC CYTOPROTECTIVE OF THE CARDIOMYOCYTE
A great imporfance of The coronary disease makes welcome any rationalinnovation in the therapy as is the case with a group of medicaments for the myocardecytoprotection primary!y by the metabolic effect; the best known of them istrimethazidine. The demand for it is obvious since even about 40% of th...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
University in Nis, Faculty of Medicine
2000-09-01
|
Series: | Acta Medica Medianae |
Subjects: | |
Online Access: | http://publisher.medfak.ni.ac.rs/2000-html/5-broj/NOVA%20KLASA%20ANTIISHEMIJSKIH....pdf |